https://www.yalemedicine.org/clinical-trials/d9350c00001phase-i-study-of-azd9592-in-solid-tumors
A Phase I, Multicenter, Open-label, First-in Human, Dose Escalation and Expansion Study of AZD9592...
This is a first-in-human (FIH) Phase I, multi-center, open-label, study of AZD9592, in patients with advanced solid tumors. The study consists of several study...
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tilatamig-samrotecan
Definition of anti-EGFR/c-Met/TOP1i ADC AZD9592 - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
definition of